VBI Vaccines’ pan-coronavirus vaccine candidate produced broad protection against variants of concern

VBI Vaccines' stock soars 18% in early trade.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.